New Jersey — Hackensack, New Jersey

New Jersey is a clinical research site located in Hackensack, New Jersey, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New Jersey has participated in 1 clinical trials.

Therapeutic areas: Partial Epilepsy.

Sponsors: Vertex Pharmaceuticals Incorporated.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey?

New Jersey has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey conducted?

New Jersey has 1 clinical trials on record. Their work covers Partial Epilepsy.

Is New Jersey accredited by Crixeo Health?

New Jersey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Jersey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.